Sopha Medical to cut staff:
This article was originally published in Clinica
French imaging company Sopha Medical is set to reduce its staff by 40% as part of the company's restructuring plans. An estimated 60 jobs will be cut from 180 in its French facility in Buc, France, and 65 from 130 in the US, says Les Echos. Sopha's chief executive, Andre Debionne, hopes to reduce losses to between Fr 30 and Fr 40 million ($8 million) in 1995 following investment of Fr 145 million by the CEA, (see Clinica No 635, p 1).
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.